SYRS | Syros Pharmaceuticals
Quick infos Headquarters: Massachusetts, United States Trade prices Volume: Market Cap: 57.17M Prev closed: Open: 2.1 High: 2.1 Low: 1.86 52 week low: 1.76 52 week high: 13.46 Dividends: No Dividends Next ER: May 10, 2023 Before Market Opens
Company Profile Syros is redefining the power of small molecules to control the expression of genes with the aim of providing a profound benefit for patients. We are advancing a pipeline of gene control medicines for cancer and monogenic diseases.
Earnings History Date EPS / Forecast Revenue / Forecast August 8, 2023 May 10, 2023 -0.85 / -1.242.95M / 4MMarch 2, 2023 -0.17 / -1.23-754K / 3.85MNovember 14, 2022 -3.21 / -3.883.9M / 5.18MAugust 9, 2022 -5.4 / -4.086.28M / 4.74MBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 8, 2023 3.03 3.14 3.14
3.03
27.7K -3.81% May 5, 2023 3.15 3.2 3.25
3.12
41.0K 0.96% May 4, 2023 3.12 3 3.16
2.96
66.2K 4.35% May 3, 2023 2.99 2.95 3.05
2.95
30.4K 1.36% May 2, 2023 2.95 3.07 3.15
2.95
77.0K -8.95% May 1, 2023 3.24 3.18 3.3
3.14
76.0K 1.89% Apr 28, 2023 3.18 3.02 3.18
2.98
98.0K 6.35% Apr 27, 2023 2.99 3.17 3.17
2.97
94.4K -5.08% Apr 26, 2023 3.15 3.04 3.18
2.95
197K 5% Apr 25, 2023 3 2.77 3.05
2.75
141K 6.38% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Syros Pharmaceuticals GAAP EPS of -$0.17 beats by $1.13 seekingalpha.com Mar 2, 2023 8:34 pm
Syros Presents New Data from Phase 1 Trial of SY-5609 and Details Three-Pronged Combination Strategy to Advance SY-5609 in Solid Tumors and Blood Cancer finance.yahoo.com Mar 2, 2023 11:30 am
TYME Technologies Shares Surge On Merger Agreement With Syros Pharma finance.yahoo.com Mar 2, 2023 7:59 am
Syros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones finance.yahoo.com Mar 2, 2023 7:32 am Syros Pharmaceuticals Q4 2022 Earnings Preview seekingalpha.com Mar 2, 2023 1:58 am Syros stock rises as tamibarotene gets FDA fast track status for rare blood cancer seekingalpha.com Jan 26, 2023 8:27 pm Syros Pharmaceuticals GAAP EPS of -$3.21 beats by $0.30, revenue of $3.9M misses by $1.28M seekingalpha.com Nov 14, 2022 8:35 pm
Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones finance.yahoo.com Mar 2, 2023 7:31 am
Syros to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 finance.yahoo.com Mar 2, 2023 7:30 am
Syros to Report Third Quarter 2021 Financial Results on Friday, November 5, 2021 finance.yahoo.com Mar 2, 2023 7:30 am
Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones finance.yahoo.com Mar 2, 2023 7:30 am
Syros Reports Second Quarter 2022 Financial Results and Provides a Corporate Update finance.yahoo.com Mar 2, 2023 7:30 am
Syros Announces Agreement with Roche to Evaluate SY-5609 as Part of a Novel Combination for Treatment of Colorectal Cancer finance.yahoo.com Mar 2, 2023 7:15 am
Mersana Therapeutics, Inc. (MRSN) Reports Q4 Loss, Tops Revenue Estimates finance.yahoo.com Mar 2, 2023 7:15 am
Syros to Participate in Upcoming Investor Conferences in March finance.yahoo.com Feb 28, 2023 7:30 am
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Feb 9, 2023 4:05 pm
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome finance.yahoo.com Jan 26, 2023 7:00 am
Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com Dec 23, 2022 4:05 pm
Syros Pharmaceuticals Announces Publication in Blood Advances Demonstrating the Potential of Tamibarotene in Patients with RARA Gene Overexpression, Supporting Ongoing Clinical Development in AML and MDS finance.yahoo.com Dec 12, 2022 7:30 am
Syros to Host Virtual Event to Discuss Initial SELECT-AML-1 Data and Unmet Need in Newly Diagnosed Unfit Acute Myeloid Leukemia on December 10 finance.yahoo.com Dec 5, 2022 7:00 am This company doesn't provide a dividend.
Key Persons CEO : Nancy A Simonian CFO : Joseph J. Ferra Chief Medical Officer : David A. Roth Talk about Syros Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?